← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3237)
- Proteomic screening identifies brusatol targets TGFβRII to suppresses non-small cell lung cancer metastasis. (2025/04/01) ♡
- N-Glycosylation Modification of Fzd4 Is Essential for the FZD4-Wnt-β-Catenin Signalling Axis. (2025/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Electroacupuncture for acute postoperative pain during coughing after video-assisted thoracoscopic surgery: study protocol for a pilot randomized controlled trial. (2025/03/26) ♡
- Study on the Material Basis and Mechanisms of Achyrocline satureioides in the Treatment of Nonsmall Cell Lung Cancer Based on Network Pharmacology and Spatial Metabolomics. (2025/03/18) ♡
- Design and Synthesis of Unsymmetric Benzils, Quinoxalines, and Evaluations of their Anticancer Activities against Human Non-Small Lung Cancer Cells. (2025/03/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Multi-tissue metabolomics and network pharmacology study on the intervention of Danggui Buxue Decoction in mice with gemcitabine induced myelosuppression. (2025/03/13) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: KRAS in stage IV non-small cell lung cancer. (2025/03/10) ♡
- Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review. (2025/03/05) ♡
- The effect of environmental stressors on the anticancer potential of Amaranthus hypochondriacus aqueous extracts and fractions. (2025/03/01) ♡
- Analysis of postoperative weight loss associated with prognosis after sublobar resections for lung cancer. (2025/03/01) ♡
- Evaluation of nutritional parameters that may be associated with survival in patients with locally advanced non-small cell lung carcinoma receiving definitive concurrent chemoradiotherapy: retrospective study conducted in a tertiary pulmonary hospital. (2025/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Comment on: Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: A systematic literature review and meta-analysis of real-world evidence. (2025/03/01) ♡
- Clinical characteristics and prognostic analysis of patients with SMARCA4-deficient lung cancer. (2025/03/01) ♡
- Basic as a binding stabilizer of microRNA-145-5p suppresses the growth of non-small cell lung cancer. (2025/03/01) ♡
- Racialized economic segregation and disparities in non-small cell lung cancer care and outcomes. (2025/03/01) ♡
- Tanreqing suppresses the proliferation and migration of non-small cell lung cancer cells by mediating the inactivation of the HIF1α signaling pathway via exosomal CIRC-WDR78. (2025/03/01) ♡
- [Guiqi Yiyuan Ointment combined with cisplatin inhibits tumor growth in Lewis lung carcinoma-bearing mice by regulating PERK/eIF2α/ATF4/CHOP signaling pathway]. (2025/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report. (2025/02/27) ♡
- Comprehensive analysis of the potential mechanism of goose onion in blocking non-small cell lung cancer progression. (2025/02/25) ♡
- Body Weight Gain Associated With Alectinib in Patients With ALK+ Non-Small Cell Lung Cancer: Pooled Analysis of Individual Patient Data From Four Prospective Clinical Trials. (2025/02/20) ♡
- IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer. (2025/02/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in clinical research of MET exon 14 skipping mutations in non-small cell lung cancer. (2025/02/12) ♡
- Huang-qin decoction increases the sensitivity of EGFR-TKis to NSCLC cells by regulating Stat3/GPX4 to induce redox ratio and ROS to inhibit CSCs. (2025/02/07) ♡
- Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-based retrospective cohort study. (2025/02/04) ♡
- Carnitine palmitoyl transferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells. (2025/02/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005). (2025/02/01) ♡
- An Exceptional Case of Garcin Syndrome Mimicking Bell's Palsy in Advanced Non-Small Cell Lung Carcinoma. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessing Outcomes in Clinical Stage I Non-small Cell Lung Tumors up to Two Centimeters in Diameter in Segmentectomy vs. Lobectomy: Systematic Review and Meta-Analysis. (2025/02/01) ♡
- A Comprehensive Quality Evaluation for Gentiana Rigescens Franch. by Fingerprinting Combined with Chemometrics and Network Pharmacology. (2025/02/01) ♡
- Low toxicity ginsenoside RG1-carbon nanodots as a potential therapeutic agent for human non-small cell lung cancer. (2025/02/01) ♡
- Panax notoginseng improves the sensitivity of non-small cell lung cancer to cisplatin by inhibiting Akt signaling. (2025/02/01) ♡
- Centipeda minima extracts and the active sesquiterpene lactones have therapeutic efficacy in non-small cell lung cancer by suppressing SKP2/p27 signaling pathway. (2025/01/31) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Investigating the antioxidant and anticancer potential of Daucus spp. extracts against human prostate cancer cell line C4-2, and lung cancer cell line A549. (2025/01/30) ♡
- Tanshinone T1/T2A inhibits non-small cell lung cancer through Lin28b-let-7-bora/MYC regulatory network. (2025/01/30) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer. (2025/01/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report. (2025/01/22) ♡
- Data analytics for real-world data integration into TKI-treated NSCLC patients using electronic health records. (2025/01/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review. (2025/01/21) ♡
- Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis. (2025/01/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Response to trastuzumab deruxtecan and delayed immune-related events in a patient with metastatic HER2-positive NSCLC: a case report and literature review. (2025/01/17) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models. (2025/01/17) ♡
- Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study. (2025/01/17) ♡
- Kanglaite alleviates lung squamous cell carcinoma through ferroptosis. (2025/01/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complex dyslipidemia induced by lorlatinib therapy: A case study. (2025/01/01) ♡
- Lymph Node Metastasis Prediction From In Situ Lung Squamous Cell Carcinoma Histopathology Images Using Deep Learning. (2025/01/01) ♡
- Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapy. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility. (2025/01/01) ♡
- Assessment of treatment effect heterogeneity for multiregional randomized clinical trials. (2025/01/01) ♡
- Two-stage Adaptive Enrichment Designs with Survival Outcomes and Adjustment for Misclassification in Predictive Biomarkers. (2025/01/01) ♡
- Study on the Mechanism of Competing Endogenous Network of 'Scutellaria barbata D.Don-Houttuynia cordata- Radix Scutellariae' in the Treatment of NSCLC based on Bioinformatics, Molecular Dynamics and Experimental Verification. (2025/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.